Integrating Novel Endpoint Development & Digital Biomarkers With Clinical Development, CMC and Market Access
Integrating Novel Endpoint Development & Digital Biomarkers With Clinical Development, CMC and Market Access Integrating Novel Endpoint Development & Digital Biomarkers With Clinical Development, CMC and Market Access The integration of novel endpoint development and digital biomarkers into clinical development processes is transforming the landscape of pharmaceutical research and development. As regulatory authorities evolve their…